Skip to content

Acupuncture and Pain Processing

Acupuncture and Pain Processing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01270607
Enrollment
10
Registered
2011-01-05
Start date
2010-04-30
Completion date
2012-08-31
Last updated
2013-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

The purpose of this study is to test the hypothesis that acupuncture will reduce Fibromyalgia pain, via alterations in the processing of pain in the central nervous system.

Detailed description

Patients and healthy controls will be enrolled in the study for a total of 6 weeks. This includes a screening and baseline visit, 8 acupuncture treatments (2 per week for 4 weeks), and a follow-up visit and treatment 1 week after completion of the study treatment sessions. To determine the effects of acupuncture on pain, patients and healthy controls will undergo psychophysical pain testing at four points throughout the study: Baseline (appointment 1), post-treatment 1 (appointment2), post treatment 8 (appointment 9), and at the final follow-up session (1 week from last treatment - appointment 10).Participants will also fill out a brief report on pain, sleep, and functioning on a palm pilot. This is expected to take less than 2 minutes per day and will occur throughout the 6 week study period.

Interventions

PROCEDUREAcupuncture

Treatment given twice per week for 4 weeks

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 18-50 2. Fibromyalgia patient OR healthy control 3. No current opioid use 4. Patients: must have had Fibromyalgia for 6 months or longer

Exclusion criteria

1. Inflammatory disorder (lupus, rheumatoid arthritis) 2. Current untreated depression 3. Active infection 4. Healthy controls: pain disorder or major medical condition that in the discretion of the investigator interfere with the validity of the study 5. Heart disease or use of a cardiac pacemaker

Design outcomes

Primary

MeasureTime frame
Pain rating to Temporal Summation and Diffuse Noxious Inhibitory Control (DNIC) as measured by a visual analogue scaleMeasured at last study acupuncture session (6 weeks post enrollment)

Secondary

MeasureTime frame
Change in Fibromyalgia Impact QuestionnaireChange from first to last study treatment session (6 weeks)
Change in Brief Pain InventoryChange from first to last treatment session (6 weeks)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026